Synapse - David Scheinberg

Results (499)

Refinements and improvements for bismuth-213 production with use as a targeted therapeutic radiopharmaceutical

Meeting Abstract

Finn, R.; McDevitt, M.; Scheinberg, D.; Jurcic, J.; Larson, S.; Sgouros, G.; Humm, J.; Curcio, M.; Brechbiel, M.; Gansow, O.; more...
Journal of Labelled Compounds and Radiopharmaceuticals (1997)

Fulltext@MSK | Save

Antibody targeted high energy alpha particle therapy: Development and use of a bismuth-213-humanized anti-CD33 agent

Meeting Abstract

Scheinberg, D. A.; Jurcic, J. G.; McDevitt, M.; Finn, R.; Larson, S. M.; Gerrlings, M. Jr; Curcio, M.; Sgouros, G.; Gansow, O.; Breitbeil, M.; more...
AAAS Annual Meeting and Science Innovation Exposition (1997)

Fulltext@MSK | Save

Pharmacokinetics and dosimetry of an alpha-particle emitter labeled anti-CD33 antibody ([213Bi]HuM195) in patients with leukemia

Meeting Abstract

Sgouros, G.; Erdi, Y. E.; Humm, J. L.; Mehta, B.; McDevitt, M. R.; Finn, R. D.; Jurcic, J. G.; Larson, S. M.; Scheinberg, D. A.
Journal of Nuclear Medicine (1997)

Fulltext@MSK | Save

Antibody mediated therapy of minimal residual leukemia: Use of humanized monoclonal antibodies and targeted alpha particles

Meeting Abstract

Scheinberg, D. A.
European Journal of Cancer (1997)

Fulltext@MSK | Save

Intracellular pH (pHi) and complement: Insertion of the membrane attack complex and complement mediated cytotoxicity are pHi dependent

Meeting Abstract

Weisburg, J. H.; Roepe, P. D.; Scheinberg, D. A.
Blood (1997)

Fulltext@MSK | Save

P190 from Philadelphia chromosome (Ph1) positive acute lymphocytic leukemia (ALL): Rapid screening for potential leukemia specific peptide antigens

Meeting Abstract

Cathcart, K. N. S.; Korontsvit, T.; Lai, L. T.; Curcio, M.; Sevrin, A.; Bocchia, M.; Tempst, P.; Scheinberg, D. A.
Blood (1997)

Fulltext@MSK | Save

Arsenic trioxide and melarsoprol induce programmed cell death in myeloid leukemia cell lines and function in a PML and PML/RARα independent manner

Meeting Abstract

Wang, Z. G.; Rivi, R.; Delva, L.; Konig, A.; Soignet, S.; Scheinberg, D.; Gambacorti-Passerini, C.; Gabrilove, J. L.; Warrell, R. P. Jr; Pandolfi, P. P.
Blood (1997)

Fulltext@MSK | Save

Molecular remission induction without relapse after anti-CD33 monoclonal antibody HuM195 in acute promyelocytic leukemia (APL)

Meeting Abstract

Jurcic, J. G.; DeBlasio, A.; Dumont, L.; Warrell, R. P. Jr; Scheinberg, D. A.
Blood (1997)

Fulltext@MSK | Save

Targeted alpha-particle therapy for myeloid leukemias: A phase I trial of bismuth-213-HuM195 (anti-CD33)

Meeting Abstract

Jurcic, J. G.; McDevitt, M. R.; Sgouros, G.; Ballangrud, A.; Finn, R. D.; Geerlings, M. W.; Humm, J. L.; Molinet, R.; Apostolidis, C.; Larson, S. M.; more...
Blood (1997)

Fulltext@MSK | Save

Melarsoprol, an organic arsenical, in the treatment of refractory leukemia: Laboratory and clinical results

Meeting Abstract

Soignet, S. L.; Rivi, R.; König, A.; Tong, W. P.; Gabrilove, J.; Scheinberg, D. A.; Pandolfi, P. P.; Warrell, R. P. Jr
Blood (1997)

Fulltext@MSK | Save